Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Since 2020, Chrysalis Capital has backed 3 African startups across 3 disclosed funding rounds totaling $29.4M, most heavily in Nigeria and Crypto & Web3.
Chrysalis Capital is an investor focused on technology and consumer businesses. Public professional profiles indicate the firm is based in Lagos, Nigeria, and that it operates as a venture capital and private equity platform, though the most authoritative publicly available details about its current structure are limited. In Africa, Chrysalis Capital has backed companies in Nigeria across multiple stages, including Pre-Seed, Series A, and Venture Round financings. Its recorded sector exposure includes crypto and Web3, fintech, and health tech, with investments in Bitmama, Bamboo, and Helium Health. The firm’s activity in the region spans April 2020 through September 2022 in the records provided. Available records also show participation alongside a wide range of co-investors, including Greycroft, Tiger Global, Motley Fool Ventures, Launch Africa, and several African venture firms. This suggests Chrysalis Capital has operated within both local and global syndicates in Nigerian startup financing.
Data updated · Aug 14, 2026
Chrysalis Capital has backed 3 African startups across 3 disclosed funding rounds tracked on Liners, totaling $29.4M since 2020.
Mostly Pre-Seed: 1 of its 3 tracked rounds are at that stage, followed by Series A (1).
Chrysalis Capital's tracked rounds are concentrated in Nigeria (3).
Its tracked rounds lean toward Crypto & Web3 (1), Fintech (1), Health Tech (1).
Chrysalis Capital most often shares rounds with Unicorn Growth Capital (1 shared deal), Launch Africa (1 shared deal), Adaverse (1 shared deal).
Chrysalis Capital has backed companies in Nigeria, according to the investment records provided. Its known African portfolio companies include Bitmama, Bamboo, and Helium Health.